Congenital Adrenal Hyperplasia
Congenital adrenal hyperplasia (CAH) is a genetic disorder that affects the adrenal glands, leading to an imbalance in hormone production, which can cause symptoms like abnormal growth patterns and hormonal imbalances.
CRN04894 for Hormonal Imbalance
We are studying the safety and effectiveness of CRN04894 in participants with hormonal imbalances. The goal is to see how it affects hormone levels and overall health.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 65 years old?
- Do you have poorly controlled blood sugar problems (diabetes) with an A1c of 8.5% or higher?
- Are you currently taking glucocorticoids like hydrocortisone, prednisone, or prednisolone?
- Are you pregnant or breastfeeding, or do you plan to become pregnant during the study?
- Have you had major surgery in the past 4 weeks?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Atumelnant
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Klinikum der Universitaet Muenchen AöR
Medizinische Klinik und Poliklinik IV
Munich, Germany
Azienda Ospedaliero-Universitaria Policlinico Umberto I
Department of Endocrinologia, Malattie del Metabolismo e Andrologia
Rome, Italy
Sponsor: Crinetics Pharmaceuticals Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.